Abstract:Oral insulin delivery has received the most attention in insulin formulations due to its high patient compliance and, more importantly, to its potential to mimic the physiologic insulin secretion seen in non-diabetic individuals. However, oral insulin delivery has two major limitations: the enzymatic barrier that leads to rapid insulin degradation, and the mucosal barrier that limits insulin’s bioavailability. Several approaches have been actively pursued to circumvent the enzyme barrier, with some of them receiving promising results. Yet, thus far there has been no major success in overcoming the mucosal barrier, which is the main cause in undercutting insulin’s oral bioavailability. In this review of our group’s research, an innovative silica-based, mucoadhesive oral insulin formulation with encapsulated-insulin/cell penetrating peptide (CPP) to overcome both enzyme and mucosal barriers is discussed, and the preliminary and convincing results to confirm the plausibility of this oral insulin delivery system are reviewed. In vitro studies demonstrated that the CPP-insulin conjugates could facilitate cellular uptake of insulin while keeping insulin’s biologic functions intact. It was also confirmed that low molecular weight protamine (LMWP) behaves like a CPP peptide, with a cell translocation potency equivalent to that of the widely studied TAT. The mucoadhesive properties of the produced silica-chitosan composites could be controlled by varying both the pH and composition; the composite consisting of chitosan (25 wt-%) and silica (75 wt-%) exhibited the greatest mucoadhesion at gastric pH. Furthermore, drug release from the composite network could also be regulated by altering the chitosan content. Overall, the universal applicability of those technologies could lead to development of a generic platform for oral delivery of many other bioactive compounds, especially for peptide or protein drugs which inevitably encounter the poor bioavailability issues.

Ionic liquids for oral insulin delivery

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Oral Ionic Liquid for Transdermal Delivery and Obesity Treatment

Ionic Liquids: Promising Approach for Oral Drug Delivery

Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions

Ionic liquid-mediated ethosome for transdermal delivery of insulin

Microcrystalline cellulose and itaconic acid pH sensitive semi-interpenetrating network hydrogel for oral insulin delivery

Formulation and Evaluation of Insulin-Loaded Sodium-Alginate Microparticles for Oral Administration

An insight into pharmaceutical challenges with ionic liquids: where do we stand in transdermal delivery?

Enhanced Transdermal Delivery of Insulin by Choline-Based Ionic Liquids

A nano-delivery system based on preventing degradation and promoting absorption to improve the oral bioavailability of insulin

Oral Insulin Delivery: A Review On Recent Advancements And Novel Strategies.

Development of inulin nanocarrier for effective oral delivery of insulin: synthesize, optimization, characterization, and biophysical study

Recent advances in oral insulin delivery technologies

Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin

A Novel Approach to Insulin Delivery via Oral Route: Milk Fat Globule Membrane Derived Liposomes as a Delivery Vehicle

Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia

Efficient oral insulin delivery enabled by transferrin-coated acid-resistant metal-organic framework nanoparticles

Overcoming Oral Insulin Delivery Barriers: Application of Cell Penetrating Peptide and Silica-Based Nanoporous Composites

Beneficial Properties for Insulin Absorption Using Superporous Hydrogel Containing Interpenetrating Polymer Network As Oral Delivery Vehicles

Mucoadhesive Ionic Liquid Gel Patches for Oral Delivery